Annual Working Capital
$27.02 M
-$57.47 M-68.02%
December 31, 2023
Summary
- As of February 7, 2025, CTMX annual working capital is $27.02 million, with the most recent change of -$57.47 million (-68.02%) on December 31, 2023.
- During the last 3 years, CTMX annual working capital has fallen by -$228.88 million (-89.44%).
- CTMX annual working capital is now -92.23% below its all-time high of $347.57 million, reached on December 31, 2018.
Performance
CTMX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$4.95 M
+$4.73 M+2130.63%
September 30, 2024
Summary
- As of February 7, 2025, CTMX quarterly working capital is $4.95 million, with the most recent change of +$4.73 million (+2130.63%) on September 30, 2024.
- Over the past year, CTMX quarterly working capital has dropped by -$49.46 million (-90.90%).
- CTMX quarterly working capital is now -98.72% below its all-time high of $386.23 million, reached on September 30, 2018.
Performance
CTMX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
CTMX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -68.0% | -90.9% |
| 3 y3 years | -89.4% | -90.9% |
| 5 y5 years | -92.2% | -90.9% |
CTMX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -88.4% | at low | -97.9% | +2130.6% |
| 5 y | 5-year | -89.4% | at low | -98.4% | +2130.6% |
| alltime | all time | -92.2% | +430.5% | -98.7% | +2130.6% |
CytomX Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.95 M(+2130.6%) |
| Jun 2024 | - | $222.00 K(-99.0%) |
| Mar 2024 | - | $22.71 M(-16.0%) |
| Dec 2023 | $27.02 M(-68.0%) | $27.02 M(-50.3%) |
| Sep 2023 | - | $54.41 M(+17.2%) |
| Jun 2023 | - | $46.42 M(-23.9%) |
| Mar 2023 | - | $61.02 M(-27.8%) |
| Dec 2022 | $84.49 M(-63.6%) | $84.49 M(-17.5%) |
| Sep 2022 | - | $102.44 M(-23.2%) |
| Jun 2022 | - | $133.33 M(-19.5%) |
| Mar 2022 | - | $165.68 M(-28.7%) |
| Dec 2021 | $232.43 M(-9.2%) | $232.43 M(+64.6%) |
| Sep 2021 | - | $141.23 M(-20.5%) |
| Jun 2021 | - | $177.63 M(-41.2%) |
| Mar 2021 | - | $301.96 M(+18.0%) |
| Dec 2020 | $255.90 M(+17.5%) | $255.90 M(+7.4%) |
| Sep 2020 | - | $238.27 M(-11.0%) |
| Jun 2020 | - | $267.78 M(-8.9%) |
| Mar 2020 | - | $294.06 M(+35.1%) |
| Dec 2019 | $217.75 M | $217.75 M(-15.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $258.65 M(-10.2%) |
| Jun 2019 | - | $288.00 M(-6.8%) |
| Mar 2019 | - | $308.86 M(-11.1%) |
| Dec 2018 | $347.57 M(+6.1%) | $347.57 M(-10.0%) |
| Sep 2018 | - | $386.23 M(+36.3%) |
| Jun 2018 | - | $283.46 M(-4.7%) |
| Mar 2018 | - | $297.32 M(-9.2%) |
| Dec 2017 | $327.45 M(+114.9%) | $327.45 M(+7.3%) |
| Sep 2017 | - | $305.13 M(+9.0%) |
| Jun 2017 | - | $280.05 M(+115.8%) |
| Mar 2017 | - | $129.78 M(-14.8%) |
| Dec 2016 | $152.38 M(-12.4%) | $152.38 M(-4.5%) |
| Sep 2016 | - | $159.63 M(-10.0%) |
| Jun 2016 | - | $177.38 M(+5.9%) |
| Mar 2016 | - | $167.54 M(-3.7%) |
| Dec 2015 | $174.01 M(+212.5%) | $174.01 M(+72.1%) |
| Sep 2015 | - | $101.10 M(-13.1%) |
| Jun 2015 | - | $116.32 M(+108.9%) |
| Dec 2014 | $55.69 M(+993.2%) | $55.69 M |
| Dec 2013 | $5.09 M | - |
FAQ
- What is CytomX Therapeutics annual working capital?
- What is the all time high annual working capital for CytomX Therapeutics?
- What is CytomX Therapeutics annual working capital year-on-year change?
- What is CytomX Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for CytomX Therapeutics?
- What is CytomX Therapeutics quarterly working capital year-on-year change?
What is CytomX Therapeutics annual working capital?
The current annual working capital of CTMX is $27.02 M
What is the all time high annual working capital for CytomX Therapeutics?
CytomX Therapeutics all-time high annual working capital is $347.57 M
What is CytomX Therapeutics annual working capital year-on-year change?
Over the past year, CTMX annual working capital has changed by -$57.47 M (-68.02%)
What is CytomX Therapeutics quarterly working capital?
The current quarterly working capital of CTMX is $4.95 M
What is the all time high quarterly working capital for CytomX Therapeutics?
CytomX Therapeutics all-time high quarterly working capital is $386.23 M
What is CytomX Therapeutics quarterly working capital year-on-year change?
Over the past year, CTMX quarterly working capital has changed by -$49.46 M (-90.90%)